Role of sarvakalpa ghan vati in liver disease.

Clinical evaluation of the therapeutic efficacy of sarvakalpa ghan vati in non alcoholic liver disorder

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025733

Enrollment

Registered

2020-06-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

Intervention1: Sarvakalpa Ghana Vati in non alcoholic liver disorder: Sarvakalpaghana Vati 2 BD oral with luke warm water after meal Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinical sign and symptoms suggesting of Yakrit Roga that is pain in right upper quadrant of stomach, Nausea, Vomiting, Loss of appetite and burning sensation in abdomen. 2. USG abdomen showing fatty infiltration of the liver. 3. LFT showing raised alanine transaminases.

Exclusion criteria

Exclusion criteria: 1. history of alcohol intake. 2. Patients with positive markers of other liver diseases such as viral hepatitis, auto immune hepatitis, wilsons disease, alpha 1 antitrypsin deficiency.

Design outcomes

Primary

Measure	Time frame
ImprovementTimepoint: 3 months	—

Secondary

Measure	Time frame
Improvement in symptoms of Yakrit rog like pain in upper quadrant of abdomen, nausea, vomiting, burning in epigastric region.Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr OP Singh

rishikul ayurvedic college, haridwar

dr.opsingh63@gmail.com9411503035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026